S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Baxter and Merrimack Pharmaceuticals Enter into Exclusive Ex-U.S. Licensing Agreement to Develop and Commercialize Novel Cancer Compound MM-398|
|Merrimack Pharma shares surge on licensing pact with Baxter|
|Merrimack Pharmaceuticals Reports Second Quarter 2014 Financial Results|
|Merrimack Pharmaceuticals Presents Additional Phase 2 Biomarker Data Further Strengthening the Finding That MM-121 Increases Progression Free Survival in Patients With Biomarker Positive Metastatic Breast Cancer|
|Keystone Property Group Closes on Acquisition of 17-17 Route 208 North in Fair Lawn, N.J. with Mack-Cali|
|Keystone Property Group Closes on Acquisition of New York and Connecticut Office Properties in Joint Venture with Mack-Cali|
|2014 Escape to Miami Triathlon Celebrates 10th Anniversary on September 28 with Mack Cycle as New Title Sponsor|
|Merrimack Pharmaceuticals Announces Initiation of HERMIONE, a Randomized Trial of MM-302 in Patients With Advanced HER2-Positive Breast Cancer to Support Application for Accelerated Approval|
|Merrimack Pharmaceuticals to Present Clinical and Biomarker Data on Novel Antibody Therapeutics at the ESMO 2014 Congress|
|Merrimack Pharmaceuticals Announces Timing of Second Quarter 2014 Investor Conference Call|
Click above to view more mutual fund data and stats for mack - Merrimack Pharmaceuticals Inc.